FEGOX | FSAGX | FEGOX / FSAGX | |
Total Expense Ratio | 1.91 | 0.68 | 281% |
Annual Report Gross Expense Ratio | 1.91 | 0.68 | 281% |
Fund Existence | 22 years | 40 years | - |
Gain YTD | 52.500 | 62.815 | 84% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.8B | 2.24B | 169% |
Annual Yield % from dividends | 3.53 | 2.29 | 154% |
Returns for 1 year | 61.18 | 75.30 | 81% |
Returns for 3 years | 82.56 | 78.85 | 105% |
Returns for 5 years | 76.74 | 63.02 | 122% |
Returns for 10 years | 174.42 | 171.21 | 102% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFCX | 11.93 | -0.07 | -0.58% |
AlphaCentric Life Sciences & Hlthcare C | |||
LMPPX | 35.78 | -0.37 | -1.02% |
ClearBridge Appreciation R | |||
TNBIX | 19.59 | -0.22 | -1.09% |
1290 SmartBeta Equity I | |||
FHOFX | 25.71 | -0.33 | -1.27% |
Fidelity Series Large Cp Grwth Idx | |||
VCGAX | 32.66 | -0.43 | -1.30% |
VALIC Company I Systematic Core Fund |